Mayo Collaborative Services v. Prometheus Laboratories, Inc.
GPTKB entity
Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:addresses |
access to medical tests
|
| gptkbp:analyzes |
innovation and public access
|
| gptkbp:court |
gptkb:Supreme_Court_of_the_United_States
|
| gptkbp:date |
2012
|
| gptkbp:decidedBy |
gptkb:United_States_Supreme_Court
|
| gptkbp:discusses |
intellectual property
the role of science in patenting |
| https://www.w3.org/2000/01/rdf-schema#label |
Mayo Collaborative Services v. Prometheus Laboratories, Inc.
|
| gptkbp:impact |
biotechnology industry
|
| gptkbp:influenced |
previous_Supreme_Court_rulings
|
| gptkbp:involves |
patent law
|
| gptkbp:is_used_in |
legal textbooks
|
| gptkbp:judges |
March 20, 2012
|
| gptkbp:landmark |
patent law history
|
| gptkbp:legal_principle |
natural laws cannot be patented
|
| gptkbp:legalStatus |
impact on patent eligibility
patent eligibility of diagnostic methods |
| gptkbp:notableFeature |
566 U.S. 66
|
| gptkbp:outcome |
invalidated patent claims
|
| gptkbp:precedent |
future patent cases
|
| gptkbp:related_to |
medical diagnostics
|
| gptkbp:resultedIn |
changes to patent law interpretation
|